Persistent glaucoma secondary to posterior subtenon steroid injection of triamcinolone acetonide (Kenalog®): case reports

摘要

PURPOSE: To describe 3 cases of children submitted to posterior subtenon steroid injection (PSSI) of triamcinolone acetonide (Kenalog® 40mg) for the treatment of intermediate uveitis, with development of refractory glaucoma. METHODS: Case report. RESULTS: Three children with the diagnosis of intermediate uveitis were treated with PSSI of triamcinolone for the control of a chronic vitreous inflammation and/or cystoid macular edema. After treatment they developed refractory glaucoma and were submitted to surgery, for removal of the steroid deposit and/or filtering surgery to control the intraocular pressure (IOP). CONCLUSION: The use of PSSI can represent a high risk for development of secondary glaucoma, with difficult control in children. Surgery to remove the remaining steroid may control IOP, but in some cases filtering surgery may be necessary.